2-(2-Chloroacetamido)propanoic acid

Catalog No.: 
ACACXZ268
CAS No.: 
1190-32-5
Molecular Formula: 
C5H8ClNO3
Molecular Weight: 
165.58
2-(2-Chloroacetamido)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$117.00InquiryInquiry
1g98%$214.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chloroacetamido)propanoic acid
IUPAC Name(2-chloroacetyl)alanine
MDL No.MFCD00020401
Molecular FormulaC5H8ClNO3
Molecular Weight165.58
SMILESCC(C(O)=O)NC(CCl)=O
InChI KeyHTAQFYLADZNZHZ-UHFFFAOYSA-N
SynonymDTXCID3031076 | Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3 | FT-0693649 | FT-0695142 | n-(chloroacetyl)alanine | Alanine, N-(2-chloroacetyl)- | UPCMLD0ENAT5989016:001 | MFCD00020401 | AMY19326 | N-Chloroacetyl-DL-alanine |
CAS No.1190-32-5
PubChem CID102573

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACACXZ268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACACXZ268 route product structure diagram
    ACACXZ2681190-32-5
Inquiry

2. ACACXZ268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACACXZ268 route product structure diagram
    ACACXZ2681190-32-5
Inquiry

3. ACACXZ268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACACXZ268 route product structure diagram
    ACACXZ2681190-32-5
Inquiry

Comments (0)